Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 118

1.

The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong Subregion: a molecular epidemiology observational study.

Imwong M, Suwannasin K, Kunasol C, Sutawong K, Mayxay M, Rekol H, Smithuis FM, Hlaing TM, Tun KM, van der Pluijm RW, Tripura R, Miotto O, Menard D, Dhorda M, Day NP, White NJ, Dondorp AM.

Lancet Infect Dis. 2017 Feb 1. pii: S1473-3099(17)30048-8. doi: 10.1016/S1473-3099(17)30048-8. [Epub ahead of print]

2.

Submicroscopic Plasmodium prevalence in relation to malaria incidence in 20 villages in western Cambodia.

Tripura R, Peto TJ, Veugen CC, Nguon C, Davoeung C, James N, Dhorda M, Maude RJ, Duanguppama J, Patumrat K, Imwong M, von Seidlein L, Grobusch MP, White NJ, Dondorp AM.

Malar J. 2017 Jan 31;16(1):56. doi: 10.1186/s12936-017-1703-5.

3.

Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration.

Srimuang K, Miotto O, Lim P, Fairhurst RM, Kwiatkowski DP, Woodrow CJ, Imwong M; Tracking Resistance to Artemisinin Collaboration..

Malar J. 2016 Nov 8;15(1):541.

4.

Prevalence of Plasmodium falciparum Molecular Markers of Antimalarial Drug Resistance in a Residual Malaria Focus Area in Sabah, Malaysia.

Norahmad NA, Mohd Abd Razak MR, Abdullah NR, Sastu UR, Imwong M, Muniandy PK, Saat MN, Muhammad A, Jelip J, Tikuson M, Yusof N, Rundi C, Mudin RN, Syed Mohamed AF.

PLoS One. 2016 Oct 27;11(10):e0165515. doi: 10.1371/journal.pone.0165515.

5.

Optimal health and disease management using spatial uncertainty: a geographic characterization of emergent artemisinin-resistant Plasmodium falciparum distributions in Southeast Asia.

Grist EP, Flegg JA, Humphreys G, Mas IS, Anderson TJ, Ashley EA, Day NP, Dhorda M, Dondorp AM, Faiz MA, Gething PW, Hien TT, Hlaing TM, Imwong M, Kindermans JM, Maude RJ, Mayxay M, McDew-White M, Menard D, Nair S, Nosten F, Newton PN, Price RN, Pukrittayakamee S, Takala-Harrison S, Smithuis F, Nguyen NT, Tun KM, White NJ, Witkowski B, Woodrow CJ, Fairhurst RM, Sibley CH, Guerin PJ.

Int J Health Geogr. 2016 Oct 24;15(1):37.

6.

Geographic distribution of amino acid mutations in DHFR and DHPS in Plasmodium vivax isolates from Lao PDR, India and Colombia.

Saralamba N, Nakeesathit S, Mayxay M, Newton PN, Osorio L, Kim JR, White NJ, Day NP, Dondorp AM, Imwong M.

Malar J. 2016 Sep 21;15(1):484.

7.

Assessing the asymptomatic reservoir and dihydroartemisinin-piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum.

Falq G, Van Den Bergh R, De Smet M, Etienne W, Nguon C, Rekol H, Imwong M, Dondorp A, Kindermans JM.

Malar J. 2016 Sep 1;15(1):446. doi: 10.1186/s12936-016-1487-z.

8.

Association between Subclinical Malaria Infection and Inflammatory Host Response in a Pre-Elimination Setting.

Peto TJ, Tripura R, Lee SJ, Althaus T, Dunachie S, Nguon C, Dhorda M, Promnarate C, Chalk J, Imwong M, von Seidlein L, Day NP, Dondorp AM, White NJ, Lubell Y.

PLoS One. 2016 Jul 7;11(7):e0158656. doi: 10.1371/journal.pone.0158656.

9.

Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors.

Phyo AP, Ashley EA, Anderson TJ, Bozdech Z, Carrara VI, Sriprawat K, Nair S, White MM, Dziekan J, Ling C, Proux S, Konghahong K, Jeeyapant A, Woodrow CJ, Imwong M, McGready R, Lwin KM, Day NP, White NJ, Nosten F.

Clin Infect Dis. 2016 Sep 15;63(6):784-91. doi: 10.1093/cid/ciw388.

10.

Erratum to: K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar.

Win AA, Imwong M, Kyaw MP, Woodrow CJ, Chotivanich K, Hanboonkunupakarn B, Pukrittayakamee S.

Malar J. 2016 May 27;15(1):297. No abstract available.

11.

Asymptomatic Plasmodium infections in 18 villages of southern Savannakhet Province, Lao PDR (Laos).

Phommasone K, Adhikari B, Henriques G, Pongvongsa T, Phongmany P, von Seidlein L, White NJ, Day NP, M Dondorp A, Newton PN, Imwong M, Mayxay M.

Malar J. 2016 May 27;15(1):296. doi: 10.1186/s12936-016-1336-0.

12.

History of malaria treatment as a predictor of subsequent subclinical parasitaemia: a cross-sectional survey and malaria case records from three villages in Pailin, western Cambodia.

Peto TJ, Kloprogge SE, Tripura R, Nguon C, Sanann N, Yok S, Heng C, Promnarate C, Chalk J, Song N, Lee SJ, Lubell Y, Dhorda M, Imwong M, White NJ, von Seidlein L, Dondorp A.

Malar J. 2016 Apr 26;15:240. doi: 10.1186/s12936-016-1284-8.

13.

Limited Polymorphism of the Kelch Propeller Domain in Plasmodium malariae and P. ovale Isolates from Thailand.

Nakeesathit S, Saralamba N, Pukrittayakamee S, Dondorp A, Nosten F, White NJ, Imwong M.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4055-62. doi: 10.1128/AAC.00138-16.

14.
15.

Parasite clearance rates in Upper Myanmar indicate a distinctive artemisinin resistance phenotype: a therapeutic efficacy study.

Tun KM, Jeeyapant A, Imwong M, Thein M, Aung SS, Hlaing TM, Yuentrakul P, Promnarate C, Dhorda M, Woodrow CJ, Dondorp AM, Ashley EA, Smithuis FM, White NJ, Day NP.

Malar J. 2016 Mar 31;15:185. doi: 10.1186/s12936-016-1240-7.

16.

Genetic Diversity of Plasmodium falciparum Populations in Malaria Declining Areas of Sabah, East Malaysia.

Mohd Abd Razak MR, Sastu UR, Norahmad NA, Abdul-Karim A, Muhammad A, Muniandy PK, Jelip J, Rundi C, Imwong M, Mudin RN, Abdullah NR.

PLoS One. 2016 Mar 29;11(3):e0152415. doi: 10.1371/journal.pone.0152415.

17.

Persistent Plasmodium falciparum and Plasmodium vivax infections in a western Cambodian population: implications for prevention, treatment and elimination strategies.

Tripura R, Peto TJ, Chalk J, Lee SJ, Sirithiranont P, Nguon C, Dhorda M, von Seidlein L, Maude RJ, Day NP, Imwong M, White NJ, Dondorp AM.

Malar J. 2016 Mar 24;15:181. doi: 10.1186/s12936-016-1224-7.

18.

Dihydrofolate-Reductase Mutations in Plasmodium knowlesi Appear Unrelated to Selective Drug Pressure from Putative Human-To-Human Transmission in Sabah, Malaysia.

Grigg MJ, Barber BE, Marfurt J, Imwong M, William T, Bird E, Piera KA, Aziz A, Boonyuen U, Drakeley CJ, Cox J, White NJ, Cheng Q, Yeo TW, Auburn S, Anstey NM.

PLoS One. 2016 Mar 1;11(3):e0149519. doi: 10.1371/journal.pone.0149519.

19.

Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction.

Awab GR, Imwong M, Pukrittayakamee S, Alim F, Hanpithakpong W, Tarning J, Dondorp AM, Day NP, White NJ, Woodrow CJ.

Malar J. 2016 Feb 25;15:121. doi: 10.1186/s12936-016-1167-z.

20.

K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar.

Win AA, Imwong M, Kyaw MP, Woodrow CJ, Chotivanich K, Hanboonkunupakarn B, Pukrittayakamee S.

Malar J. 2016 Feb 24;15:110. doi: 10.1186/s12936-016-1147-3. Erratum in: Malar J. 2016;15(1):297.

Items per page

Supplemental Content

Loading ...
Support Center